What Is The Long-term Outlook for AMC Stock?
Meme stock extraordinaire AMC Entertainment Holdings, Inc. (NYSE:AMC) has long…
Sell
41
VERA Quote, Financials, Valuation and Earnings
Last price:
$23.32
Seasonality move
:
35.97%
Day range:
$21.43 - $22.87
52-week range:
$18.53 - $51.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.69x
Volume:
1.8M
Avg. volume:
2.3M
1-year change:
-35.28%
Market cap:
$1.4B
Revenue:
--
EPS (TTM):
-$3.00
Earnings Data
Next earnings date for VERA
Aug 08
2025
Most recent earnings per share
-$0.81
Missed by $0.03
(May 6/2025)
Consensus Estimate
-$0.78
(May 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
VERA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/08/2025 | Q2 | -- | -- | -- | -$0.62 | -- |
| 05/06/2025 | Q1 | -- | -- | -$0.81 | -$0.78 | -$0.03 |
| 12/31/2024 | Q4 | -- | -- | -$0.72 | -$0.73 | $0.01 |
| 11/07/2024 | Q3 | -- | -- | -$0.85 | -$0.62 | -$0.23 |
| 08/08/2024 | Q2 | -- | -- | -$0.62 | -$0.54 | -$0.08 |
| 05/09/2024 | Q1 | -- | -- | -$0.56 | -$0.56 | -$0.00 |
| 03/28/2024 | Q4 | -- | -- | -$0.58 | -$0.51 | -$0.07 |
| 11/09/2023 | Q3 | -- | -- | -$0.45 | -$0.54 | $0.09 |
| 08/10/2023 | Q2 | -- | -- | -$0.46 | -$0.74 | $0.28 |
| 05/11/2023 | Q1 | -- | -- | -$0.80 | -- | -- |
| 03/28/2023 | Q4 | -- | -- | -$1.19 | -- | -- |
| 11/09/2022 | Q3 | -- | -- | -$0.91 | -- | -- |
| 08/10/2022 | Q2 | -- | -- | -$0.55 | -- | -- |
| 05/16/2022 | Q1 | -- | -- | -$0.71 | -- | -- |
| 03/24/2022 | Q4 | -- | -- | -$0.79 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$0.36 | -- | -- |
| 08/16/2021 | Q2 | -- | -- | -$0.33 | -- | -- |
| 06/24/2021 | Q1 | -- | -- | -$0.23 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$10.52 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$1.09 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.88 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.61 | -- | -- |
Vera Therapeutics Earnings Questions
-
How Much did Vera Therapeutics Generate in Revenue Last Quarter?
Vera Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Vera Therapeutics Beat Earnings Last Quarter?
Vera Therapeutics announced earnings per share of -$0.81 which represents a miss of analyst forecast a -$0.78 per share.
-
Is Vera Therapeutics Profitable?
Vera Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Vera Therapeutics EPS Next Year?
Vera Therapeutics's earnings are forecast to decrease from -$2.75 per share to -$2.79 per share next year representing a decrease of -23.13%.
-
When is Vera Therapeutics's Earnings Date?
Vera Therapeutics's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NuScale the Best Nuclear Stock to Buy?
NuScale Power (NYSE:SMR) is a nuclear power startup that has…
Where Will Kestra Medical Stock Be in 1 Year?
Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 42x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 50x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
58
AMBA alert for Jun 25
Ambarella [AMBA] is up 4.36% over the past day.
Buy
65
EXOD alert for Jun 25
Exodus Movement [EXOD] is down 9.63% over the past day.
Buy
78
SMR alert for Jun 25
NuScale Power [SMR] is down 10.59% over the past day.
